Here are the S-3 shelf registrations from Bio Green Med Sluti 6%PFD (BGMSP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow BGMSP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BGMSP filings page.
Bio Green Med Solution, Inc. (BGMS) is registering up to 1,103,338 common shares for resale by selling stockholders, who may sell only after the registration statement is effective. The shares were issued in a private placement that closed June 10, 2026, at $0.72 per share for $794,403 in aggregate gross proceeds. Selling stockholders receive proceeds from resales; BGMS receives none.
Separately, BGMS has proposed acquiring 100% of Future NRG Sdn. Bhd. for a number of BGMS shares calculated by dividing $2,000,000,000 by BGMS’s 30-day volume-weighted average price immediately before closing. If completed, Future NRG shareholders are expected to own more than approximately 99.0% of BGMS’s outstanding common stock, while current BGMS stockholders are expected to own less than approximately 1.0%. Completion is subject to stockholder approval and other customary conditions; either party may terminate if the exchange has not closed by December 31, 2026. BGMS’s incorporated audit report includes an explanatory paragraph about substantial doubt regarding its ability to continue as a going concern.